Cashew allergy treatment: building long-term tolerance
Part of Immune system & allergy clinical trials.
This study tests whether people who already completed cashew oral immunotherapy can stop eating cashew protein and still be protected from allergic reactions. It helps researchers understand if the treatment leads to lasting tolerance.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed cashew nut allergy.
- You already finished the first part of this study and reached the maintenance dose of 1200 mg of cashew protein.
- You and/or your parent or guardian agree to take part and sign a consent form.
- You are willing and able to cooperate with the study procedures.
- You do NOT have severe or poorly controlled asthma, recent anaphylaxis, or certain chronic illnesses.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if children who already reached a maintenance dose of sesame protein in a previous immunotherapy can stop treatment and stay unresponsive to sesame. It aims to see if the protection lasts over time.
This trial tests whether a specially boiled cashew nut can help children with cashew allergy eat cashews without a reaction. It is for children ages 2 to 17 with a confirmed cashew allergy, and it avoids other serious health conditions.
This study tests a treatment that gradually exposes children to small amounts of peanut and certain tree nuts to reduce their allergy. It aims to help children safely tolerate multiple nuts at once.
This study tests whether a treatment program can help children and teenagers with peanut allergies develop tolerance to peanuts over time. The goal is to reduce the risk of serious allergic reactions if they accidentally eat peanuts.
This study watches how milk and egg allergies change naturally over time or after oral immunotherapy (OIT) in children. It helps researchers understand how the immune system adapts, aiming to improve treatment for food allergies.
This trial tests whether giving very small amounts of cashew protein (like a food immunotherapy) can help children and teens with cashew allergy become less allergic. If it works, it might lower the risk of severe reactions.
Hear when a new Food Allergy in Children trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.